NASD · Healthcare · Biotechnology · Australia
Immutep Limited ADR is a micro cap company (market value under $300 million) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Immutep Limited ADR stock.
Undervalued: intrinsic value $9.61 per share, market price $3.06, margin of safety 68.2% (as of 2026-10-30).
A 2.4x revenue multiple, discounted for its losses, values the shares at $9.61; the price of $3.06 is 68% below that value.
IMMP is undervalued (as of the 2026-10-30 close). A 2.4x revenue multiple, discounted for its losses, values the shares at $9.61; the price of $3.06 is 68% below that value.
$9.61 per share (as of the 2026-10-30 close), against a market price of $3.06. That is a margin of safety of 68.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.